XFOR
X4 Pharmaceuticals Inc
NASDAQ: XFOR · HEALTHCARE · BIOTECHNOLOGY
$4.07
-0.73% today
Updated 2026-04-30
Market cap
$374.59M
P/E ratio
—
P/S ratio
10.67x
EPS (TTM)
$-1.87
Dividend yield
—
52W range
$1 – $5
Volume
0.5M
X4 Pharmaceuticals Inc (XFOR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |